Pick the Right Pathway: How 505(b)(2) Beats the Branded Generic Every Time — Unless It Doesn’t
In the fiercely competitive world of pharmaceuticals, choosing the right pathway for drug approval can make or break a company’s market strategy. The stakes are high—timing, costs, and market exclusivity all hinge on this decision. Yet, many companies …
